ArticleClinical and translational medicine2026

Targeted demethylation of the BRD7 promoter based on CRISPR/dCas9 system inhibits the malignant progression of nasopharyngeal carcinoma.

Jianxia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.